perflutren has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, K; Suzuki, R | 1 |
| Maruyama, K; Matsumura, Y; Namai, E; Negishi, Y; Oda, Y; Sawamura, K; Suzuki, R; Takizawa, T; Tanaka, K; Utoguchi, N | 1 |
2 other study(ies) available for perflutren and Sarcoma 180
| Article | Year |
|---|---|
Effective in vitro and in vivo gene delivery by the combination of liposomal bubbles (bubble liposomes) and ultrasound exposure.
Topics: Animals; Ascites; Chlorocebus aethiops; COS Cells; Cricetinae; DNA; Fluorocarbons; Genes, Reporter; Genetic Therapy; Humans; Injections, Intra-Arterial; Liposomes; Male; Mice; Microbubbles; Plasmids; Sarcoma 180; Transfection; Ultrasonics | 2010 |
Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles.
Topics: Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; DNA; Erythrocytes; Fluorocarbons; Gene Targeting; Genetic Therapy; Hemolysis; Liposomes; Male; Mice; Sarcoma 180; Transfection; Ultrasonics | 2008 |